These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 19383433)
21. Mechanical stress and prostaglandin E2 synthesis in cartilage. Gosset M; Berenbaum F; Levy A; Pigenet A; Thirion S; Cavadias S; Jacques C Biorheology; 2008; 45(3-4):301-20. PubMed ID: 18836232 [TBL] [Abstract][Full Text] [Related]
22. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Hughes D; Otani T; Yang P; Newman RA; Yantiss RK; Altorki NK; Port JL; Yan M; Markowitz SD; Mazumdar M; Tai HH; Subbaramaiah K; Dannenberg AJ Cancer Prev Res (Phila); 2008 Sep; 1(4):241-9. PubMed ID: 19138967 [TBL] [Abstract][Full Text] [Related]
23. Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E(2) production and neurodegeneration in cortical and hippocampal cell cultures. Kim EJ; Lee JE; Kwon KJ; Lee SH; Moon CH; Baik EJ Brain Res; 2001 Jul; 908(1):1-9. PubMed ID: 11457426 [TBL] [Abstract][Full Text] [Related]
24. Regulation of COX-2 mediates acid-induced bone calcium efflux in vitro. Krieger NS; Frick KK; LaPlante Strutz K; Michalenka A; Bushinsky DA J Bone Miner Res; 2007 Jun; 22(6):907-17. PubMed ID: 17352658 [TBL] [Abstract][Full Text] [Related]
25. Indomethacin increases 15-PGDH mRNA expression in HL60 cells differentiated by PMA. Frenkian M; Pidoux E; Baudoin C; Segond N; Jullienne A Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):87-93. PubMed ID: 11237475 [TBL] [Abstract][Full Text] [Related]
27. NS398 protects cells from sodium nitroprusside-mediated cytotoxicity through enhancing HO-1 induction independent of COX-2 inhibition. Nizamutdinova IT; Lee JH; Seo HG; Chang KC; Kim HJ Arch Pharm Res; 2009 Jan; 32(1):99-107. PubMed ID: 19183882 [TBL] [Abstract][Full Text] [Related]
28. Regional differences in prostaglandin E₂ metabolism in human colorectal cancer liver metastases. Young AL; Chalmers CR; Hawcroft G; Perry SL; Treanor D; Toogood GJ; Jones PF; Hull MA BMC Cancer; 2013 Feb; 13():92. PubMed ID: 23442768 [TBL] [Abstract][Full Text] [Related]
29. Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer. Kochel TJ; Fulton AM Prostaglandins Other Lipid Mediat; 2015; 116-117():99-103. PubMed ID: 25433169 [TBL] [Abstract][Full Text] [Related]
30. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. Backlund MG; Mann JR; Holla VR; Buchanan FG; Tai HH; Musiek ES; Milne GL; Katkuri S; DuBois RN J Biol Chem; 2005 Feb; 280(5):3217-23. PubMed ID: 15542609 [TBL] [Abstract][Full Text] [Related]
31. Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors. Pham H; Chen M; Li A; King J; Angst E; Dawson DW; Park J; Reber HA; Hines OJ; Eibl G Pancreas; 2010 Apr; 39(3):332-9. PubMed ID: 19820419 [TBL] [Abstract][Full Text] [Related]
32. Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer. Kochel TJ; Reader JC; Ma X; Kundu N; Fulton AM Oncotarget; 2017 Jan; 8(4):6540-6554. PubMed ID: 28029661 [TBL] [Abstract][Full Text] [Related]
34. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167 [TBL] [Abstract][Full Text] [Related]
35. Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo. Huang CF; Li G; Ma R; Sun SG; Chen JG Neurosci Bull; 2008 Apr; 24(2):66-72. PubMed ID: 18369384 [TBL] [Abstract][Full Text] [Related]
36. Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase. Wakimoto N; Wolf I; Yin D; O'Kelly J; Akagi T; Abramovitz L; Black KL; Tai HH; Koeffler HP Cancer Res; 2008 Sep; 68(17):6978-86. PubMed ID: 18757412 [TBL] [Abstract][Full Text] [Related]
37. Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid. Carlson NG J Neurosci Res; 2003 Jan; 71(1):79-88. PubMed ID: 12478616 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents. Cho H; Tai HH Prostaglandins Leukot Essent Fatty Acids; 2002 Dec; 67(6):461-5. PubMed ID: 12468268 [TBL] [Abstract][Full Text] [Related]
39. Prostaglandins compromise basal forebrain cholinergic neuron differentiation and survival: action at EP1/3 receptors results in AIF-induced death. Jonakait GM; Ni L Brain Res; 2009 Aug; 1285():30-41. PubMed ID: 19555672 [TBL] [Abstract][Full Text] [Related]
40. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway. Zhang H; Ye Y; Bai Z; Wang S Dig Dis Sci; 2008 Aug; 53(8):2195-203. PubMed ID: 18320325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]